Concepedia

Joseph Cheriyan

JC

42

Publications

2.5K

Citations

30

H-Index

2005

Active since

Affiliations

University of Cambridge(Current)

Cambridge University Hospitals NHS Foundation Trust

Addenbrooke's Hospital

GlaxoSmithKline (United States)

University of Edinburgh

Joseph Cheriyan is an author at University of Cambridge specializing in medicine, vascular biology, and pharmacology.

ORCID

Top concepts

Publications per year

2005–2023

42

Publications

42

Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis

Kaisa Mäki-Petäjä, Maysoon Elkhawad, Joseph Cheriyan et al. · Circulation · 2012 · 212 citations

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor

Aili L. Lazaar, Lucy Yang, Rebecca Boardley et al. · British Journal of Clinical Pharmacology · 2015 · 171 citations · Full text

Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist

Aimée Brame, Janet J. Maguire, Peiran Yang et al. · Hypertension · 2015 · 151 citations · Full text

, , +22

Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis

Maysoon Elkhawad, James H.F. Rudd, Lea Sarov‐Blat et al. · JACC. Cardiovascular imaging · 2012 · 149 citations

, , +10

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects

Navin Goyal, Peter J. Skrdla, Rosemary Schroyer et al. · American Journal of Cardiovascular Drugs · 2019 · 139 citations · Full text

Rows per page

1–5 of 42